Final

og

pr

ram
©overcome

WITH SUPPORT OF THE JOURNAL

1

Dear Colleagues and friends,
We are pleased to welcome you to EUMS-ISMCS joint scientific conference with the common goal toshare knowledge and mutually discuss evidence, experiences, trends, perspectives and visions for the
future mechanical circulatory support.
Yours faithfully, on behalf of the whole scientific and local committee,
Prof. Dr. Jan D. Schmitto(President of the EUMS-Society 2022)
SCIENTIFIC COMMITTEE
J. Bauersachs, Hannover - GER
A. El Banayosy, Oklahoma City - USA
G. Dogan, Hannover - GER
L. Fresiello, Enschede - NLD
A. Haverich, Hannover - GER
J. Karimov, Cleveland - USA
G. Laufer, Vienna - AUT
A. Loforte, Bologna - ITA
F. Moscato, Vienna - ITA
P. Leprince, Paris - FRA
J. D. Schmitto, Hannover - GER
T. Schoeglhofer, Vienna - AUT
M. Slepian, Tucson - USA
G. Tansley, Gold Coast - AUS
D. Zimpfer, Vienna - AUT

LOCAL ORGANIZATION COMMITTEE
J. Bauersachs, Hannover - GER
D. Berliner, Hannover - GER
E. Deniz, Hannover - GER
G. Dogan, Hannover - GER
J. Hanke, Hannover - GER
K. Homann, Hannover - GER
T. Li, Hannover - GER
A. S. Merzah, Hannover - GER
F. S. Merzah, Hannover - GER
L.C. Napp, Hannover - GER
J. Optenhöfel, Hannover - GER
E. Rausch, Hannover - GER
K. Roske, Hannover - GER
K.Stelter, Hannover - GER
A. Schöde, Hannover - GER
J. D. Schmitto, Hannover - GER

LOGISTICS ORGANISATION AND PARTNERSHIPOVERCOME
13-15, Rue des Sablons 75116 Paris, France
Ph: +33 (0)1 40 88 97 97
Fax: +33 (0)1 43 59 76 07
E-mail: eums@overcome.fr

LOCATION: CONFERENCE CENTER SCHLOSS HERRENHAUSEN
Herrenhauser St. 5 - 30419 HANNOVER, Germany

2

MONDAY, MAY 23

9:00-13:00 Workshop: Hands-on-animal-training: VAD-implantation in cooperation
with CORZA Medical at the campus of Hannover Veterinary School of Medicine, Hannover

TUESDAY, MAY 24
AUDITORIUM
Lower level

09:30
11:00

11:00
12:00

ROOM 4Ground floorRoleof the VAD
Coordinator+Management

12:00
12:15

BOARDROOM
Upper level

EXHIBITION
Upper level10.00 - 12.00
ISMCS
Executive
meeting

Coffee Break

12:15
13:15

Technical
supervisionin timesof COVID-19

13:15
14:00

Lunch Break

14:00
15:00

15:00
17:45

ROOM 6Lower floor

13.00 -16.00
ISMCS
Board
of Trustees

Driveline
Infection /PatientManagement

3

WEDNESDAY, MAY 25

09:00
10:30

AUDITORIUM
Lower
level

ROOM 1
Groundfloor

ROOM 2Groundfloor

ROOM 3Groundfloor

EUMS
ISMCS-ESAO

Trainings
Village

Trainings
Village

VAD-Village

10:30
11:00

ROOM 4Groundfloor

ROOM «ECHO» EXHIBITION
Lower
Upper
level
level

Exhibition

Coffee BreakCoffee BreakPatientag:
Leben mit einem
Herzunterstützungssystem

11:00
13:00

RVAD
and
BIVAD

Trainings
Village

Cytosorbents
lunch
symposium

14:15
15:15

Short-term
supportTrainings
Village

Trainings
Village

RecoveryTrainings
Village

Trainings
Village

16:45
17:15
17:15
19:15

19:30
22:00

VAD-Village

Exhibition
12.30-13.30
Patientag:
Rund um das
Herzunterstützungssystem

13:15
14:15

15:15
16:45

4

Trainings
Village

VAD-Village

VAD-Village

Exhibition

15:00-16:00
15:30-17:00
Patientag: VAD Echo-course
als Brücke zur VAD-patientson
Transplantation

Exhibition

Coffee BreakJoint
EUMS-ISMCS
Opening
Ceremony

Exhibition

Welcome cocktail reception in the exhibition area

THURSDAY, MAY 26
AUDITORIUM
Lower
level

07:30
08:30

Abbottsymposium

08:30
10:00

VAD Session

ROOM 1
Groundfloor

ROOM 2Groundfloor

ROOM 3Groundfloor

Trainings
Village

Trainings
Village

VAD-Village

10:00
10:30
Pro/Cons
Debates 1
ISMCS

12:15
13:15

Carmatlunch
symposium

13:15
14:45

Interdisciplinary
session EUMS /ISMCS
and EACTAIC
Perioperative
managementof ventricularassist devices

Trainings
Village

Trainings
Village

14:45
15:15

16:45
18:30

EXHIBITION
Upper
level

Exhibition

Coffee Break

10:30
12:00

15:15
16:45

ROOM 4Groundfloor

Trainings
Village

Trainings
Village

VAD-Village

Rapid-Fire
Abstract
SessionExhibition

VAD-Village

13.30 -14.30
ISMCS
GeneralAssembly

Exhibition

Coffee BreakAcute session:short term
Trainings
Village

Trainings
Village

VAD-Village

Exhibition

VAD updates

5

FRIDAY, MAY 27

08:30
10:00

AUDITORIUM
Lower
level

ROOM 1
Groundfloor

ROOM 2Groundfloor

ROOM 3Groundfloor

MCS under
the hoodTrainings
Village

Trainings
Village

VAD-Village

10:00
10:30

TAH update

12:45
13:45

Abiomedlunch
symposium

13:45
14:45

Marketdevelopment
and Futureof MCS

Trainings
Village

Trainings
Village

Trainings
Village

Trainings
Village

FutureTechnologies

16:45 EUMS-ISMCS
Closing
17:45
ceremony

6

11:00 - 12:00
Echo-course
on VAD
patients

VAD-Village

Exhibition

VAD-Village

Exhibition

Coffee Break

Trainings
Village

18:00
19:00

Coffee Break

13:30 - 15:30
Joint-EUMS
Perfusionist
Meeting

14:45
15:15
15:15
16:45

ROOM BOARDROOM EXHIBITION«Echo»
Upper
Upper
Lower level
level
level

Exhibition
09:30 - 11:45
Joint-EUMS
Perfusionist
Meeting

Coffee Break

10:30
12:30

ROOM 4Groundfloor

Trainings
Village

15:30 - 18:00
VAD-Village Joint EUMSKFO Meeting

Exhibition

ISMCS
Strategy
meetingfor board
membersonly

n TUESDAY, MAY 24, 2022
09:30 CEST
12:00

VAD COORDINATOR MEETING
ROLE OF THE VAD COORDINATOR AND MANAGEMENT

Room 4Chairs: S. Mariani, Maastricht - BEL, A. Schöde, Hannover - GER
J. D. SCHMITTO, HANNOVER - GERnWelcome and Overviewn

The Role of the VAD Coordinator: US Perspective

J. WU, SAN FRANCISCO - USAn

The Role of the VAD Coordinator: EU Perspective

A. SCHÖDE, HANNOVER - GERn

Anticoagulation Practices in LVAD PatientsF. MÜLLER, HOMBURG - GERnSpecial patients - special databases

S. FISCHER, HANNOVER - GERnInflow Cannula Position as Risk Factor for Hemocompatibility Related Adverse Events in LVAD
T . SCHLÖGLHOFER, VIENNA - AUT
Patients

BOARDROOM

10:00 CEST
ISMCS EXECUTIVE MEETING
12:00

12:15 CEST VAD COORDINATOR MEETING
13:15
TECHNICAL SUPERVISION IN TIMES OF COVID-19

Chairs: A. El Banayosy, Oklahoma City - USA, T. Schlöglhofer, Vienna - AUT, J. Wu, San Francisco - USA
Room 4nnnEnhanced technical patient management: logfiles, acoustic analysis and more
F. KAUFMANN, BERLIN - GER
Telemonitoring VAD patients COVID-19

V. LAUENROTH, BAD OEYNHAUSEN - GER”Patients first” - digital LVAD patient and first responder engagement software
J. HAJJ, CHARLESTON - USA

Room 613:00 CEST
ISMCS BOARD OF TRUSTEES
16:00

7

n TUESDAY, MAY 24, 2022
15:00 CEST VAD COORDINATOR MEETING
17:45
DRIVELINE INFECTION /PATIENT MANAGEMENT

Chairs: A. Loforte, Bologna - ITA, H. Niehaus, Hannover - GER, F. Müller, Homburg - GER
Driveline Infections: Surgical remediation and alternatives
J. HANKE, HANNOVER - GER - K.HOMANN, HANNOVER - GER
n Driveline management with cold plasma therapy
L. TRENDL, BAD ROTHENFELDE - GERn Cardiac Rehabilitation of LVAD patients
K. VANDERSMISSEN, LEUVEN - BEL
n Staying Active on an LVAD
S. KORE, MANCHESTER - GBRn Palliative Care in LVAD patients
A.-M. OPPELAAR, UTRECHT - NLDn Alternative ways of carrying backpacks for VAD patients
F. FATTEICHER - GER

Room 4n

8

n WEDNESDAY, MAY 25, 2022
09:00 CEST
EUMS-ISMCS-ESAO
10:30

AUDITORIUM

Chairs: B. Glasmacher, Hannover - GER - S. Jacob, Leuven - BEL - U. Steinseifer, Aachen - GERn HEMO compatibility the Big Picture : now and in the future
M. SLEPIAN, TUCSON - USA

EUMS TRAININGS – VILLAGE

ROOM 1-2

ALL DAY

Visualize hemolysis with ghost cells – a feasibility study for mechanical hemolysis detection
B. SCHUERMANN, AACHEN - GERn Key note lecture: on control strategies
H. SCHIMA, VIENNA - AUS
n Hemodynamic limitations and challenges in LVAD technology
L. FRESIELLO, ENSCHEDE - NLD
n 3D-planing of complex operations
S. SONNTAG, MUNICH - GERn Treatment of biofilm-infested implants - A tissue-saving approach
H. ROTERING, MÜNSTER - GERn RVAD in pulmonary hypertension: experimental and preliminary clinical experience
T. VERBELEN, LEUVEN - BELn

VAD VILLAGE

ROOM 3

ALL DAY

Coffee break in the exhibitors’ area
11:00 CEST
RVAD AND BVAD
13:00

Chairs: A. Loforte, Bologna - ITA, E. Potapov, Berlin - GER, J. Riebandt, Vienna - AUT,
n Key note lecture: the use of isolated RVADs
E. RAME, PHILADELPHIA - USA
n The failing RV in the setting of LVAD
O. SOLIMAN, GALWAY - IRLn Clinical experiences with (oxy) RVADs
S. MARIANI, MAASTRICHT - NLD
Combination of pulsatile and continuous flow devices in challenging cases - proof of concept
J. GARBADE, BREMEN - GERn Pulsatile RVAD: from short term to permanent pulsatile VAD
A. RUHPARWAR, ESSEN - GERn Universal Ventricular Assist device (UVAD)
J. KARIMOV, CLEVELAND - USA

AUDITORIUMn

An in vitro model to study suction events in ventricular assist device patients: validation withclinical data
M. ROCCHI, LEUVEN - BEL
n Machine learning based blade design optimisation of the NeoVAD
L. NISSIM, BATH - GBRn A new algorithm for anticoagulation management with the HearMate
F. CONSOLO, MILANO - ITAnØ Discussions
9

n WEDNESDAY, MAY 25, 2022
13:15 CEST THE ROLE OF CYTOSORB-THERAPY IN HIGH-RISK CARDIAC SURGERY PATIENTS
14:15
Lunch symposium with the support of Cytosorbents

AUDITORIUM

Chairs: F. Pappalardo, Alessandria - ITA, L.C. Napp, Hannover - GERnnn

Cytokine absorbtion in Aortic dissections

H. JAKOB, ESSEN - GER

Reduction of bleeding complications in ticagrelor and rivaroxaban loaded patients
S. GEIDEL, HAMBURG - GER
ECMO plus CytoSorb – it needs an individualized approach

A. MONTISCI, BRESCIA - ITA

Ø Discussions
14:15 CESTSHORT-TERM SUPPORT
15:15

AUDITORIUM

Chairs: A. El Banayosy, Oklahoma City - USA, J. Hanke, Hannover - GER, J. Karimov, Cleveland - USAn

Transition from ECLS to durable MCS: when and how?

A. LOFORTE, BOLOGNA - ITAnAssessing the right ventricle on VA-ECMO

D. DONKER, UTRECHT - NLDnDe-escalate and ambulate: from ECMO to Impella

L.C. NAPP, HANNOVER - GERnExperience from short - to longterm tx in Middle East

A. SIMON, RIYAD - SAU

15:15 CESTRECOVERY
16:45

AUDITORIUM

Chairs: G. Laufer, Vienna - AUT, U. Tegtbur, Hannover - GER, Y. Barac, Haifa - ISR
Update recovery: actual status, knowledge and future outlooknWeaning protocolnCardiac Recovery in LVAD patients: Oeynhausen experience R. SCHRAMM, BAD OEYNHAUSEN - GERnBerlin Health C-MIC microcurrent device

P. GÖTTEL, BERLIN - GERnPhysiology of LV long axis shortening

J. BERG, LUND - SWEnMechanical circulatory support for HFpEF

B. KUBAN, CLEVELAND - USAnUpdate on Barostimulation for the treatment of heart failure

M. KNAUT, DRESDEN - GERn

Syntach: A Novel Minimally Invasive Cardiac Support System

K. SOLEM, LUND - SWE

Ø Discussions

10

M. BONIOS, SALT LAKE CITY - USAnJ. MULZER, BERLIN - GER

n WEDNESDAY, MAY 25, 2022

ROOM “Echo”

15:30 CEST
ECHO-COURSE ON VAD PATIENTS
17:00

Coffee break in the exhibitors’ area
17:15 CESTJOINT EUMS-ISMCS OPENING CEREMONY
19:30

AUDITORIUM

Chairs: El Banayosy, Oklahoma City - USA, P. Leprince, Paris - FRA, J. D Schmitto, Hannover - GER
P. LEPRINCE, PARIS - FRA
A. LOFORTE, BOLOGNA - ITAnEUMS-ISMCS Joint MeetingnWelcome address B. THÜMLER, MINISTER OF SCIENCE AND CULTURE, STATE OF LOWER SAXONY, HANNOVER - GERnWelcome address

T. HERMANN, MAYOR OF THE CITY OF HANNOVER - GERnWelcome address

M. MANNS, PRESIDENT OF HANNOVER MEDICAL SCHOOL - GERnWelcome address

A. HAVERICH, CHIEF OF CARDIAC SURGERY, HANNOVER - GERn

ISMCS President key lecture

A. EL BANAYOSY, OKLAHOMA CITY - USAn

EUMS President key lecture

J. D SCHMITTO, HANNOVER - GERnHemolytic footprint of rotodynamic blood pumpsn

A. ESCHER, VIENNA - AUT

Artificial pulse: effect on pump washout and thrombogenicity of the HeartMate 3
D. DE ZELICOURT, ZURICH - CHEnDevelopment of Heart reimplacement therapy

J. LONG, OKLAHOMA CITY - USAnHistory of MCS

G. WIESELTHALER, VIENNA - AUT

Ø Discussions

EXHIBITION AREA

19:30 CESTWELCOME COCKTAIL
22:00

11

n THURSDAY, MAY 26, 2022

AUDITORIUM

07:30 CEST ABBOTT BREAKFAST SYMPOSIUM
08:30
WITH SUPPORT OF ABBOTT

Chairs: P. Leprince, Paris - FRA, J. D. Schmitto, Hannover - GERn The evolution of LVAD therapy and an exciting perspective on the future R. KORMOS, AUSTIN - USA
n HeartMate 3 and its growing body of evidence: establishing LVAD therapy as standard of care
J. GARBADE, BREMEN - GERn Ongoing clinical trials: a key to further increase adoption of LVADs H. ROBBE,BRUSSELS - BEL
n Recognizing advanced HF: joining forces to improve referral practice F. GUSTAFSSON, COPENHAGEN - DNK

Chairs: G. Dogan, Hannover - GER, R. Kormos, Austin - USA, H. Reichenspurner, Hamburg - GERn Current Guidelines for VAD-therapy
P. MOHASCI, GRAZ - AUTn Indication and patient selection
D. BERLINER, HANNOVER - GERn EUROMACS update
T. DE BY, WINDSOR - GBRn INTERMACS update
F. PAGANI, ANN ARBOR - USA
n Early-VAD study update
C. KNOSALLA, BERLIN - GERn Is there a sex gap in long-term outcomes of comparable patients dupported with left ventricularassist devices?
T. LI, HANNOVER - GER
n18F-FDG PET/CT analyses in patients with left ventricular assist devices – longitudinal vascularburden of inflammation and impact on cerebrovascular events
J. HUPE, HANNOVER - GER

ALL DAY

EUMS TRAININGS – VILLAGE

ROOM 1-2

AUDITORIUM

08:30 CESTVAD SESSION
10:00

VAD VILLAGE

ROOM 3

ALL DAY

Coffee break in the exhibitors’ area

AUDITORIUM

10:30 CEST
PRO/CONS DEBATES - EUMS / ISMCS
12:00

12

Chairs: E. Rame, Philadephia - USA, K. Toda, Osaka - JPN
n Debate 1- Early VAD in chronic heart failure – PRO- Early VAD in chronic heart failure – CONØ Discussionsn Debate 2- Impella not ECMO
- ECMO not Impella?
Ø Discussionsn Debate 3- TAH- HM6 or Centrifugal TAH
Ø Discussions

D. ZIMPFER, VIENNA - AUT
J. BAUERSACHS, HANNOVER - GER
R. DOWLING, HERSHEY - USA
N. KAPUR, BOSTON - USA
I. KNESEVICZ, LJUBLJANA - SVN
M. STRUEBER, MEMPHIS - USA

n THURSDAY, MAY 26, 2022
10:30 CEST
RAPID-FIRE ABSTRACTS SESSION
12:00

Chairs: L. Fresiello, Enschede - NLD, J. Karimov, Cleveland - USA, G. Tansley, Gold Coast - AUSn A device strategy-matched comparison analysis among different INTERMACS profiles: single
center experience
R. CARAFFA, PADOVA - ITA
The effect of RVAD implantation site on the risk of right intracardiac thrombosis
K. Y. THUM, MELBOURNE - AUS
n Cold Atmospheric Plasma (CAP) Treatment Options For Foreign Body Associated Infections In
Patients With Left Ventricular Assist Devices
L. HILKER, KARLSBURG - GERnn

A Genetic Algorithm-based Optimization Framework For Control Parameters Of Ventricular
Assist Devices
K. MAGKOUTAS, ZÜRICH - SWI

The R-wave amplitude to detect acute preload changes in patients with a ventricular assist
deviceS. A. DUAL, PALO ALTO - USAn Effect of pulsatile mechanical circulatory support on cardiac mechanics
M. BARROS ROTTERDAM - NLD

ROOM 4nnnn

30 day survival after temporary right ventricular assist devices implantation: a systematic
review
O. SOLIMAN, GALWAY - IRE
A pulsatile mock circulatory loop for the evaluation of cardiac assist device haemocompatibility
T. SING, GOLD COAST - AUS
Minimally Invasive Aortic Valve Replacement with an Expandable Bioprosthesis after LVAD
Implantation as Redo Surgery
A. F. POPOV, SIEGBURG - GER

Numerical hemocompatibility evaluation of a novel total artificial heart – The Shuttlepump
K. NARAYANASWAMY, VIENNA - AUT
n Cardiac ventricular fibrosis in patients with advanced biventricular heart failure undergoing
durable mechanical circulatory support
M. J. BONIOS, ATHENS - GRC
n

AUDITORIUM

12:15 CEST THE FUTURE OF ADVANCED HEART FAILURE - CARMAT’S VISION
13:15
Lunch symposium with the support of Carmat

Chairs: El Banayosy, Oklahoma City - USA, J. D Schmitto, Hannover - GERn CARMAT’s approach to the treatment of advanced heart failure
S. PIAT, CARMAT®
n Timing and Indications for Aeson implantation
G. DOGAN, HANNOVER - GER®
n Surgical technique for the implantation of Aeson
A. VINCENTELLI, LILLE - FRA®
n Aeson acquired hemocompatibility
C. MILANO, DURHAM - USA

13

n THURSDAY, MAY 26, 2022

AUDITORIUM

13:15 CEST INTERDISCIPLINARY SESSION EUMS/ISMCS AND EACTAIC
14:45
Perioperative management of ventricular assist devices

Chairs: M. Freundt, Hershey - USA, M. Jüttner, Hannover - GER, E. de Waal, Utrecht - NLD
n Welcomen Preoperative optimization of the patients scheduled for LVAD implantation C. STOPPE, WÜRZBURG - GERn Coagulation disorders prior to LVAD implantation
I. BIRSCHMANN, BAD OEYNHAUSEN - GERn Right heart Failure: risk stratification and strategies
V. VON DOSSOW, BAD OEYNHAUSEN - GERn Intraoperative general and hemodynamic management
N. MARCZIN, LONDON - GBRn Vasoplegia after LVAD implantation
E. DE WAAL, UTRECHT - NLD
n Strategies for Early Postoperative Recovery
E. TSCHERNKO, VIENNA - AUTn Anestheasia for non-VAD surgeries in VAD patients
J. F. KARSTEN, HANNOVER - GER

Room 4

13:30 CEST
ISMCS GENERAL ASSEMBLY
14:30

Coffee break in the exhibitors’ area

AUDITORIUM

15:15 CEST
ACUTE SESSION: SHORT TERM
16:45

Chairs: P. Leprince, Paris - FRA, B.Kuban, Cleveland - USAn Has short-term mechanical circulatory support an impact on post-heart transplant vasoplegia?
F. LOPEZ VALDIVIEZO, BARCELONA - ESP
n What device for which patients?
A. EL BANAYOSY, OKLAHOMA CITY - USAn Left ventricle unloading improves the in-hospital survival of pediatric congenital heart disease
patients supported with veno- arterial extracorporeal life support P. MEANI, MAASTRICHT - NLD
n Refractory CS: from last 3CT meeting
A. MEBAZZA, PARIS - FRAn Is surgical approach using an external ventricular assist device better than ECMO in refractory
cardiogenic shock?
G. CALADO RIBEIRO, CAMPINAS - BRE

AUDITORIUM

16:45 CEST
VAD UPDATES
18:15

14

Chairs: A. Popov, Siegburg - GER, G. Tansley, Gold Coast - AUS, D. Zimpfer, Vienna - AUTn magAssist Update
C-H. HSU, SUZHOU - CHN
n The MI-VAD Pump: a novel approach to permanent cardiac assist S. KUSHWAHA, MINNEAPOLIS - USA
n Corwave
T. SNYDER, CLICHY - FRA
n InvivoPower: Invivopower link: a novel transcutaneous energy transfer technology for long-term
mechanical circulatory support
B. BERN, MÖLNDAL - SWE
n RAP-Pump
H. HORN - GERn Vadovation
J. LONG, OKLAHOMA CITY - USAn Adjucor: ReBEAT - Introducing a novel biventricular mechanical circulatory support device thatavoids blood contact
U. STOCK, LONDON, GBR
n CH Biomedical update
F. LIN, TORRANCE - USA
n Evaheart updates
R. DOWLING, HERSHEY - USA

n FRIDAY, MAY 27, 2022

AUDITORIUM

08:30 CESTMCS UNDER THE HOOD
10:00

EUMS TRAININGS – VILLAGE

ROOM 1-2

ALL DAY

Chairs: L. Fresiello, Enschede - NLD, P. Ivak, Prague – CZE, D. Zimpfer, Vienna - AUTn Intelligent systems for long term cardiac monitoring
S. DUAL, STANFORD - USA
n Proteins, Biomarkers and New Devices
C. BARTOLI, PHILADELPHIA - USAn Non-invasive monitoring of HeartMate 3 LVAD patient
S. SECER, HAMBURG - GERn Establishment of a national Heart Failure-Network
T. KEMPF, HANNOVER - GERn Microembolic signal monitoring in patients with HeartMate 3 and HeartWare
K. RAVENBERG, HANNOVER - GERn Markers of neutrophil extracellular traps (NETs) in patients with left ventricular assist device
a prognostic factor for cerebrovascular events?
M. GABRIEL, HANNOVER - GER

VAD VILLAGE

ROOM 3

ALL DAY

Coffee break in the exhibitors’ area

AUDITORIUM

10:30 CESTTAH UPDATE
12:30

Chairs: G. Dogan, Hannover - GER, M. Morshuis, Bad Oeynhausen - GER, D. Wiedemann, Vienna - AUT
n Carmat
P . LEPRINCE, PARIS - FRA
n Real heart
I.-L. PERKINS, VÄSTERÅS, REAL HEART - SWE
n Bivacor
D. TIMMS, HOUSTON, BIVACOR - USAn Cleveland Clinic Total Artificial Heart
J. KARIMOV, CLEVELAND - USA
n Biological TAH: padua project
G. GEROSA, PADUA - ITAn TAH-HeartMate 6
P. IVAK, PRAGUE - CZEn The ShuttlePump - a novel pulsatile valveless total artificial heart
T. BIEREWIRTZ, BERLIN - GER
n Heart Hackathon - An international student team competition developing the next generationof artificial hearts
S. GREGORY, MELBOURNE - AUS
n Experiences with the HeartMate 3 Modular Driveline Cable and Driveline Exchange
A. MERZAH, HANNOVER - GERn SynCardia
S. LANGFORD, SYNCARDIA

Ø Discussions15

n FRIDAY, MAY 27, 2022

ROOM “Echo”

11:00 CEST
ECHO-COURSE ON VAD PATIENTS
12:00

AUDITORIUM

12:45 CEST ANY NEWS ON THE VALUE OF PMCS SUPPORT STRATEGIES?
13:45
Lunch symposium with the support of Abiomed

Chairs: J. D. Schmitto, Hannover - GER, D. Zimpfer, Vienna - AUT
n Escalation & de-escalation strategies with pMCS & corresponding value of SOP’s
L.C. NAPP, HANNOVER - GERn Bridge to decision or bridge to device – How can pMCS be supportive?
A. BERNHARDT, HAMBURG - GERn What about PCCS – any options to support myocardial recovery?
M. OEZKUR, MAINZ - GERn How to support in Cardiac Surgery with pMCS – single center experience
A. EL BANAYOSY, OKLAHOMA CITY - USA,

13:15 CEST
MARKET DEVELOPMENT AND FUTURE OF MCS
14:45

AUDITORIUM

Chairs: P. Leprince, Paris - FRA, A. Loforte, Bologna - ITA, J. D. Schmitto, Hannover - GER
Market development
Outcome variation through centers
n Robotic left ventricular assist device implantationn Xenotransplantation – Where we are today?
n Wish list for future VAD-therapynn

J. LONG, OKLAHOMA CITY - USA
N. URIEL, NEW YORK - USA
Z. KHALPEY, TUCSON - USA
A. HAVERICH, HANNOVER - GER
J. D SCHMITTO, HANNOVER - GER

Ø Discussions
Coffee break in the exhibitors’ area
15:15 CEST
FUTURE TECHNOLOGIES
16:45

Chairs: L. Fresiello, Enschede - NLD, M. Granegger, Vienna - AUT, J. Hanke, Hannover - GER
Impella 5.5 and BTR: update session
C. NIX, AACHEN, ABIOMED - GEn Procyrion
J. HEURING, HOUSTON - USA
n NuPulse
V. JEEVERNANDAM, CHICAGO - USAn EMKA Medical
R. GLOCKER, ASCHAFFENBURG - GERn Corolla
Y. FELD, TEL AVIV - ISRn Future outlook: relevance of electrical microcurrent in recovery
J. MÜLLER, BERLIN - GERn Pulsecath
O. MALCHIN, ARNHEM - NEDn HFpEF devices
M. GRANEGGER, VIENNA - AUT

AUDITORIUMnØ Discussions
16

n FRIDAY, MAY 27, 2022

AUDITORIUM

15:30 CESTJOINT SESSION EUMS-KFO MEETING
17:00

Chairs: J. Bauersachs, Hannover - GER, S. Cebotari, Hannover - GERn Molecular imaging of the failing Heart and device-related complications
J. DIEKMANN, HANNOVER - GERn Ex-vivo cardiac surgery using the Organ Care System
A. MARTENS, HANNOVER - GERn Protein based therapie for myocardial infarction
K.C. WOLLERT, HANNOVER - GERn Iron defiency aggravates heart failure
T. KEMPF, HANNOVER - GERn Overview of existing large animal models in Hannover
T. MEYER, MEDIMPLANT

AUDITORIUM

16:45 CEST
EUMS-ISMCS CLOSING CEREMONY
17:45

Chairs: A. El Banayosy, Oklahoma City - USA, A. Loforte, Bologna - ITA,
J. D Schmitto, Hannover - GERn Awardsn Presentation of EUMS 2023 (Paris, France)
P. LEPRINCE, PARIS - FRAn Presentation of ISMCS 2023 (USA)A. EL BANAYOSY, OKLAHOMA CITY - USAn Closing words of the Joint-EUMS-ISMCS-Conference-2022
J. D SCHMITTO, HANNOVER - GER

BOARDROOM

18:00 CEST
ISMCS STRATEGY MEETING
19:00

17

n PATIENTAG
MITTWOCH, 25. MAI
German language session/Deutschsprachige Sitzung
10:30 CESTLEBEN MIT EINEM HERZUNTERSTÜTZUNGSSYSTEM
12:30

Chairs: Günes Dogan Oberarzt, Facharzt für Herzchirurgie
Alexandra Schöde VAD-Koordinatorin Medizinische Hochschule Hannover
In Begrüßung durch
JAN D. SCHMITTO, PRÄSIDENT EUMS SOCIETY
Die Entwicklung des VAD-Programmes in Hannover: Innovationen und Pionierarbeiten
JAN D. SCHMITTOn Mein Leben mit dem Herzunterstützungssytem “Heartware HVAD”
RENE FIEBIGn 10 Jahre nach minimal-invasiver LVAD-Implantation (“HVAD”) in HannoverJÖRG BÖCKELMANN
n “The one and only” – Erfahrungen eines “MVAD”- Patienten
HERMANN LAUKART
n “First in man”! Erinnerungen und Erlebnisse in ca. 8 Jahren mit “HM 3”
KURT-JOSEF MÜLLER
n Ambulante Nachsorge nach VAD-Implantation
HEIDI NIEHAUS MEDIZINISCHE HOCHSCHULE HANNOVER

Seminarraum 4nn

12:30 CEST
RUND UM DAS HERZUNTERSTÜTZUNGSSYSTEM
13:30

Chairs: Jasmin S. Hanke, Medizinische Hochschule HannoverKatharina Homann, VAD - Koordination Medizinische Hochschule Hannover
HM 3 Aufbau und Funktion
HOLGER KASTNING FIRMA ABBOTT
A-Arbeits-und Erwerbsfähigkeit, Schwerbehinderten-, Transportausweis nach Implantation,
Umgang mit den Krankenkassen
ANJA VAJEN KLINCK FALLINGBOSTELn Fahrdienst Südheide- alles rund um die Transporte von VAD- Patienten
STEPHAN STREUBEL KT SÜDHEIDEn Alternative Lösungen und innovative Möglichkeiten zum Tragen von VAD-Systemen
FANNY FATTEICHER FIRMA MEDITXn Professionelle Rehabilitation nach VAD-Implantation
SUSANNE BRUNNER CHEFÄRZTIN KARDIOLOGIE KLINIK FALLINGBOSTEL

Seminarraum 4nn

15:00 CEST
VAD ALS BRÜCKE ZUR TRANSPLANTATION
16:00

Seminarraum 4

Chairs: Ezin Deniz MD Medizinische Hochschule Hannover
Silke Feueriegel VAD-Koordination Medizinische Hochschule Hannover

18

10 Jahre Support mit VAD und anschließender Herztransplantation
HANS VEEGER
Reisen und Leben mit einem VAD und nach Herztransplantation
ALGIRD DIKSCHATn ”Pulslos-leben e.V.” - Verein für VAD-Patienten und AngehörigeJÖRG BÖCKELMANNn Verabschiedung durch
GUNES DOGAN MEDIZINISCHE HOCHSCHULE HANNOVERnnn JOINT-EUMS-PERFUSIONIST-MEETING
FREITAG 27. MAI
German language session/Deutschsprachige Sitzung

Seminarraum 4

09:30 CESTPERFUSION SESSION 1
11:45

Chairs: Günes Dogan Oberarzt, Facharzt für Herzchirurgie
Sebastian Tiedge, Medizinische Hochschule Hannovern Kommunikation in interprofessionellen Teams - Wie können wir Fehler vermeiden?
C. MACKE, HANNOVER - GER
n Heater Cooler Unit - Endlich eine saubere Lösung
M. BONGERT, DORTMUND - GERn First clinical experiences with the CARL - System
C. BENK, FREIBURG - GERn Lebensrettende extrakorporale Lebenserhaltung und linksventrikuläre Entlastung: ein Widerspruchin sich?
J. GEHRON, GIESSEN - GER
n Mobilität und Bewegungsfreiheit für Patienten mit angeborenem Herz F. MÜNCH, ERLANGEN - GERn Fallvorstellung und diskussion
A. MERZAH, HANNOVER - GER

Seminarraum 4

13:30 CESTPERFUSION SESSION 2
15:30

Chairs: Jasmin S. Hanke, Medizinische Hochschule HannoverFrank Münch, Universität Erlangenn Qualifikation und Verantwortlichkeiten eines klinischen Perfusionisten - heute und in Zukunft
A. BAUER, COSWIG - GERn In Silico Analyse der Einflüsse auf die innere und äußere Strömung einer ECMO-Kanüle
M. BONGERT, DORTMUND - GERn Korreliert die computergestützte ECMO-Simulation mit der klinischen Realität?
D. BUCHWALD, BOCHUM - GER
n vv is not va! Phatophysiological differences between ECMO types
A. BAUER, COSWIG - GERn Herausforderungen und Fallstricke bei ECLS/ECMO-Transporten
S. TIEDGE, HANNOVER - GERn Fallvorstellung: Herausforderung in ECMO Transport
A. MERZAH, HANNOVER - GER

19

NOTES

20

NOTES

21

THANK TO OUR MAJOR SPONSORS 

THANK TO OUR SPONSORSn GENERAL INFORMATION 
CONGRESS VENUECONFERENCE CENTER HERRENHAUSEN:
Veranstaltungs und Betriebs GmbH,
Ph.: +49 511 763744-0

LOGISTICAL ORGANIZATION AND REGISTRATIONOVERCOME: 13-15, rue des Sablons - 75116 PARIS, France
Ph: +33(0)1 40 88 97 97 - Fax: +33 (0)1 43 59 76 07 - E-mail: eums@overcome.fr

REGISTRATIONOn site registration
Physician/Engineer

550 €Nurse/Perfusionist/Resident

250 €Virtual fee – all conferences

300 €Daily virtual fee

100 €Congress Dinner

100 €ACCOMMODATION
A limited number of rooms at preferential rates have been booked for the EUMS delegates.
For individual reservations, you can book directly online through your registration profile
For company and or third party reservations, please send your request to:
OVERCOME – HOUSING DEPARTMENT
Ph : +33(0)1 40 88 97 97
e-mail: eumshousing@overcome.fr

EXHIBITION
From Wednesday, May 25, a large exhibition will take place in the Ballroom (upper floor) hosting industry partners.
Startups will be waiting for you close to the auditorium (lower floor).

TRANSPORTATION

16th European Mechanical Circulatory support Summit” 38342AF valid from 17/05/2022 to 03/06/2022

23

Technology for life
magAssist is one of the leading innovators of healthcare companies in China.
We have been determined to develop circulatory support devices
for acute/severe cardiac and pulmonary failure.

m

A s s isa gt

Our pipeline includes extracorporeal ventricular assist device (Extra-VAD),
percutaneous ventricular assist device (P-VAD),
extracorporeal membrane oxygenation systems (ECMO)
and organ care systems.

www.magassist.com.cn
TECHNOLOGY FOR LIFE
科技转动生命